Search Results 181-190 of 17106 for immunothérapie
Mayo Clinic researchers identify how P2RX7-driven regulatory T cells promote immunotherapy resistance in lung cancer, pointing to a potential new treatment ...
The first thing to do when a patient is diagnosed is I tell that patient, this is a scary moment. We understand that. Take a deep breath. As you come to see me ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
Personalized care. At Mayo Clinic, an expert team of hematologists, medical oncologists, radiation oncologists, pathologists and other specialists, if needed, ...
This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in combination with ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
CAR-T cell therapy is a treatment that uses genetically altered immune cells to fight cancer. Learn how it works, why it's done and what results may show.
To assess whether health promotion tools such as psychoeducation applied to non-distressed breast cancer patients will result in lower distress at 3, 6, 9 & 12 ...
This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!